For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250623:nRSW8948Na&default-theme=true
RNS Number : 8948N Clean Power Hydrogen 23 June 2025
23 June 2025
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group")
CPH2 Activates First Licenced Manufacturing Partnership with Hidrigin
Highlights:
· First licence package submitted, enabling Hidrigin and Jones Engineering
to begin manufacturing preparations for MFE220 electrolysers in Ireland
· Hidrigin expects construction of the units to begin in Q4 2025, with
first electrolysers ready for deployment in 2026
· Major milestone in CPH2's commercialisation stage, advancing its
capital-light licensing model
CPH2, the UK-based green hydrogen technology and manufacturing company that
has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased
to announce the submission of its first manufacturing and design licence
documentation ("licence package") to Lisheen H2 Energy Park Limited, which
trades under the name Hidrigin. This submission enables Hidrigin and its
appointed manufacturing partner, Jones Engineering Manufacturing Limited
("Jones"), to initiate preparations for production of MFE220 electrolysers in
Ireland under the existing 2GW licence agreement. The comprehensive licence
package consists of: a process, mechanical, electrical and safety design
package; a bill of materials with every part defined; and a 3D layout defined
for the electrolyser and all sub-assemblies.
This marks a major commercial milestone for CPH2, activating its first
manufacturing licensee and advancing its capital-light licensing model.
Under the 20-year licence, Hidrigin intends to deploy MFE220 electrolysers
across its solar PV and wind projects in Ireland. With the submission of the
licence pack, preparation activities are now underway by Hidrigin and Jones
which include staff training, supplier engagement, and production facility
planning. Production is scheduled to commence in Q4 2025, with the first units
expected to be operational in 2026.
Jon Duffy, CEO of Clean Power Hydrogen commented:
"Activating our first licensee through the submission of this licence package
to Hidrigin is a pivotal step in our commercialisation strategy. Our licensing
model allows us to scale quickly and efficiently while leveraging the
strengths of local partners. We are excited to support Hidrigin and Jones
Engineering as they move towards production of the MFE220, and we look forward
to further progress with our additional licensees during the course of 2025."
Eric Whelan, CEO of Hidrigin commented:
"Receiving the licence package from CPH2 is a major milestone in our mission
to deliver green hydrogen. The technical depth and clarity of the materials
give us full confidence as we begin preparations with our partners at Jones
Engineering. We aim to commence production in Q4 2025 and deploy our first
unit in 2026. This is the beginning of our ambition to link renewable energy
with sustainable hydrogen production in Ireland and beyond."
ENDS
For more information, please contact:
Clean Power Hydrogen plc via Camarco
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald +44 (0)131 220 9771
Peter Lynch +44 (0)131 220 9772
Adam Rae +44 (0)131 220 9778
Camarco PR + 44(0) 20 3 757 4980
Owen Roberts
Kirsty Duff
To find out more, please visit: https://www.cph2.com (https://www.cph2.com)
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited which has
almost a decade of dedicated research and product development experience. This
experience has resulted in the creation of simple, safe and sustainable
technology which is designed to deliver a modular solution to the hydrogen
production market in a cost-effective, scalable, reliable and long-lasting
manner. The Group's strategic objective is to deliver the lowest LCOH in the
market in relation to the production of green hydrogen. CPH2 is listed on the
AIM market and trades under the ticker LON:CPH2.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCPPUCCQUPAGMP